AbbVie
USA · Pharma & Healthcare
Also known as: Abbvie
LeaveRussia detail: Continue Operations
Global 500
AbbVie is an American publicly traded biopharmaceutical company founded in 2013.
Decision trail
Decision date 19/03/2022 · Reference ↗
AbbVie has temporarily suspended operations for the aesthetics products in Russia and paused the start of new clinical studies. Other operations are continued. Revenue increased in 2024 vs 2023 by more than +50%.
Local stats (LeaveRussia)
Assets(RF), mln.USD
179
Capital(RF), mln.USD
132
Glob.Revenue, mln.USD
58054
Revenue(RF), mln.USD
169
Staff(RF), 2021
303
Taxes(RF), mln.USD
34
Status history since 2022
- 03/08/2026 — operating · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional